346 related articles for article (PubMed ID: 32896582)
21. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease.
Nguyen HMT; Anaissie J; DeLay KJ; Yafi FA; Sikka SC; Hellstrom WJG
J Sex Med; 2017 Oct; 14(10):1220-1225. PubMed ID: 28874331
[TBL] [Abstract][Full Text] [Related]
23. Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling.
Fernández-Pascual E; González-García FJ; Angulo J; Cerezo E; Quintana LM; Turo J; Martínez-Ballesteros C; Carballido J; Martínez-Salamanca JI
BJU Int; 2019 Dec; 124(6):1055-1062. PubMed ID: 31033130
[TBL] [Abstract][Full Text] [Related]
24. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
[TBL] [Abstract][Full Text] [Related]
25. Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease.
Yafi FA; Anaissie J; Zurawin J; Sikka SC; Hellstrom WJ
J Sex Med; 2016 Apr; 13(4):684-9. PubMed ID: 27045265
[TBL] [Abstract][Full Text] [Related]
26. Characteristics predictive of response to collagenase clostridium histolyticum for Peyronie's disease: a review of the literature.
Masterson TA; Rezk A; Ramasamy R
World J Urol; 2020 Feb; 38(2):279-285. PubMed ID: 31250098
[TBL] [Abstract][Full Text] [Related]
27. Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.
El-Khatib FM; Towe M; Yafi FA
World J Urol; 2020 Feb; 38(2):299-304. PubMed ID: 31093703
[TBL] [Abstract][Full Text] [Related]
28. Treatment-related Outcomes for Patients With Atypical Peyronie's Disease Using Xiaflex Injections.
El-Khatib FM; Osman MM; Kopelevich A; Towe M; Yafi FA
Urology; 2020 Sep; 143():153-158. PubMed ID: 32590080
[TBL] [Abstract][Full Text] [Related]
29. Intralesional collagenase
Chung E; Wang J
Investig Clin Urol; 2022 Sep; 63(5):563-568. PubMed ID: 36068002
[TBL] [Abstract][Full Text] [Related]
30. Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
Sukumar S; Pijush DB; Brandes S
J Sex Med; 2020 Jan; 17(1):111-116. PubMed ID: 31759930
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).
Carson CC; Sadeghi-Nejad H; Tursi JP; Smith TM; Kaufman GJ; Gilbert K; Honig SC
BJU Int; 2015 Nov; 116(5):815-22. PubMed ID: 25818264
[TBL] [Abstract][Full Text] [Related]
32. Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).
Natale C; McLellan DM; Yousif A; Hellstrom WJG
Sex Med Rev; 2021 Apr; 9(2):340-349. PubMed ID: 32199788
[TBL] [Abstract][Full Text] [Related]
33. Multi-institutional Prospective Analysis of Intralesional Injection of Collagenase Clostridium Histolyticum, Tunical Plication, and Partial Plaque Excision and Grafting for the Management of Peyronie's Disease.
Yafi FA; Diao L; DeLay KJ; DeYoung L; Talib R; Alzweri L; Brock G; Hellstrom WJG; Hatzichristodoulou G
Urology; 2018 Oct; 120():138-142. PubMed ID: 30059716
[TBL] [Abstract][Full Text] [Related]
34. Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact.
Gabrielson AT; Spitz JT; Hellstrom WJG
Sex Med Rev; 2018 Jan; 6(1):143-156. PubMed ID: 28454897
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of collagenase Clostridium histolyticum in men with congenital penile curvature.
Kulkarni Y; Green B; Pattillo C; Stirland I; Flores A; Ziegelmann M; Kohler T; Helo S; Trost L
J Sex Med; 2023 Feb; 20(2):194-199. PubMed ID: 36763911
[TBL] [Abstract][Full Text] [Related]
36. Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie's disease.
Gannon MK; Pearlman AM
BMC Urol; 2021 Jun; 21(1):94. PubMed ID: 34176473
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of Collagenase Clostridium histolyticum (Xiapex
Cocci A; Di Maida F; Russo GI; Capogrosso P; Francesco L; Rizzo M; Di Mauro M; Salonia A; Cito G; Falcone M; Romano A; Polloni G; Martinez-Salamanca JI; Fernández-Pascual E; Minervini A; Mondaini N
Clin Drug Investig; 2020 Jun; 40(6):583-588. PubMed ID: 32342279
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
[TBL] [Abstract][Full Text] [Related]
39. Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis.
Nguyen HMT; Yousif A; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M; Hellstrom WJG
Urology; 2020 Nov; 145():147-151. PubMed ID: 32777367
[TBL] [Abstract][Full Text] [Related]
40. Second cycle of intralesional Collagenase Clostridium histolyticum for Peyronie's disease using the modified shortened protocol: Results from a retrospective analysis.
Capece M; Arcaniolo D; Manfredi C; Palmieri A; De Sio M; Verze P; Fusco F; Longo N; Mirone V
Andrologia; 2020 Apr; 52(3):e13527. PubMed ID: 32003061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
